GlaxoSmithKline receives boost in China
A two-dose course of its cervarix jab was approved for use on Chinese girls aged between nine and 14 in a bid to prevent cervical cancer.
Eslam Saleh
0
4
A two-dose course of its cervarix jab was approved for use on Chinese girls aged between nine and 14 in a bid to prevent cervical cancer.
